Menu
Recruiting NCT07288476

Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics

No phase Interventional Pediatric Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: educational video.
Who it may be relevant to
Registry conditions: Pediatric Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Families of children with cancer who speak languages other than English experience inequalities in healthcare, but little research has been done on solutions to improve care for these families. This study will partner parents with medical interpreters and clinicians to create educational videos about key cancer topics in Spanish and test their use as a tool to improve caregiver knowledge and experience in the setting of a language barrier. The project will lead to a future career development award application that increases the number of available languages and studies how multilingual educational videos impact caregiver knowledge and experience

Interventions

  • Other educational video
    Spanish-language video to impart knowledge and understanding to parents caring for children with cancer

Primary outcome measures

  • Feasibility of Implementing a Spanish-Language Educational Video Intervention [Time frame: 6 months]
  • Acceptability of Implementing a Spanish-Language Educational Video Intervention [Time frame: 6 months]
Secondary outcome measures (1)
  • Impact on caregiver knowledge measured by post-intervention surveys [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

Aims 1 and 2 (Video Development Phase):

  • Legal caregiver aged ≥18 years of a child/young adult (0-25 years) undergoing active cancer treatment in low-intensity phases or off therapy.
  • Native or fluent Spanish speaker.
  • Willing and able to provide verbal consent.
  • Willing to comply with study procedures and be available for the study duration.

Aim 3 (Video Pilot Phase):

  • Legal caregiver aged ≥18 years of a child/young adult (0-25 years) with newly diagnosed or relapsed/refractory cancer (≤1 month).N
  • Native or fluent Spanish speaker.
  • Requires an interpreter for medical conversations.
  • Willing and able to provide verbal consent.
  • Willing to comply with study procedures and be available for the study duration.

Exclusion criteria

Aims 1 and 2:

  • Insufficient cognitive functioning to complete study procedures (as determined by PI).
  • Caregiver of a child/young adult who did not receive cancer-directed therapy.
  • Caregiver of a child/young adult receiving high-intensity cancer treatment.
  • Unable to read and speak Spanish fluently.

Aim 3:

  • Insufficient cognitive functioning to complete study measures (as determined by PI).Caregiver of a child/young adult who did not receive cancer-directed therapy.
  • Caregiver of a child/young adult not receiving cancer-directed therapy.
  • Diagnosis of new or relapsed/refractory cancer occurred >1 month prior to enrollment.
  • Unable to speak Spanish fluently.
  • Does not require an interpreter for medical conversations.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Children's Hospital Colorado — Aurora

Identifiers

NCT: NCT07288476 · 25-0595.cc · NCI-2025-08026

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗